Table 10. Estimated 12-month prevalence for cognitive doping by using RRT.
Population | ‘Yes’ | ‘No’ | 95% CI | |||
All athletes (response rate = 91.6%) | 724 | 2013 | 0.265 | 15.1% | 0.00016 | 12.7–17.6 |
Physical enhancement | ||||||
‘Yes’ | 147 | 235 | 0.385 | 33.0% | 0.00092 | 25.8–40.3 |
‘No’ | 555 | 1741 | 0.242 | 11.7% | 0.00012 | 9.1–14.3 |
Cognitive enhancement | ||||||
‘Yes’ | 77 | 79 | 0.494 | 49.2% | 0.00239 | 37.5–60.9 |
‘No’ | 625 | 1897 | 0.248 | 12.6% | 0.00011 | 10.1–15.1 |
Location | ||||||
Frankfurt | 226 | 609 | 0.271 | 16.0% | 0.00052 | 11.5–20.5 |
Regensburg | 242 | 643 | 0.274 | 16.4% | 0.00050 | 12.1–20.8 |
Wiesbaden 70.3 | 256 | 761 | 0.252 | 13.2% | 0.00041 | 9.2–17.1 |
Gender | ||||||
Male athletes | 632 | 1726 | 0.268 | 15.6% | 0.00018 | 13.0–18.3 |
Female athletes | 82 | 267 | 0.235 | 10.7% | 0.00114 | 4.1–17.3 |
A-level | ||||||
‘Yes’ | 430 | 1189 | 0.266 | 15.3% | 0.00027 | 12.1–18.5 |
‘No’ | 207 | 638 | 0.245 | 12.2% | 0.00049 | 7.9–16.5 |
Structured training plan | ||||||
‘Yes’ | 475 | 1310 | 0.266 | 15.4% | 0.00024 | 12.3–18.4 |
‘No’ | 246 | 696 | 0.261 | 14.6% | 0.00045 | 10.4–18.8 |
Behavior in case of pain | ||||||
Take a pause | 413 | 1243 | 0.249 | 12.9% | 0.00025 | 9.8–16.0 |
Continue | 301 | 739 | 0.289 | 18.8% | 0.00044 | 14.7–22.9 |
(CI = confidence interval).